Treatment gap exists, but the reasons for the care disparity aren't entirely clear.
Each of these diagnoses has many implications for both nurses and patients. When combined, nurses need to anticipate that these patients may have greater psychosocial challenges.
Longer survival can raise the risk of anal, colorectal, and liver cancers, researchers find.
HIV has been linked to increased risk for colorectal, lung, skin, and breast cancers, independent of treatment.
Proportion undergoing testing varies by demographic and health-related factors, and by state, a study found.
Only 41% of cancer survivors in the U.S. under 65 reported ever having a human immunodeficiency virus (HIV) test.
Adding steroids for the treatment of tuberculosis pericarditis in patients co-infected with HIV may increase the risk of cancer.
HIV-infected people with early stage cancer are two to four times more likely to go untreated for their cancer compared to uninfected patients with cancer, according to a new, large retrospective study.
HIV-infected individuals with cancer are less likely to receive treatment, according to a study published online in the Journal of Clinical Oncology.
Researchers have discovered a promising new way to treat a rare and aggressive blood cancer that is most commonly found in people infected with HIV.
HIV-positive patients have a higher incidence of nonmelanoma skin cancers. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive persons.
In 2010, 32 percent had received three doses of vaccine; incidence of some HPV-linked cancers up.
High incidence compared to general population, especially for men who have sex with men.
Based on the current literature associating human papillomavirus (HPV) with head and neck cancer, what public health initiatives need to be implemented?
Targeted prophylaxis strategy is most cost-effective in highest risk men who have sex with men.
Phase 2 study shows overall response rate of 31 percent in patients with poor-prognosis HIV-KS.
Drugs to keep HIV-infected women from transmitting virus to fetus may trigger cleft defects.
- Cancer-related Neuropathy May Respond to Gene Therapy
- No Clinical Benefit to Expanding Gene Panel Beyond Ovarian and Breast Cancer Genes in High-risk Women
- A Protein Could Predict the Response to Immunotherapy in Metastatic Melanoma
- Clinical Results Matches Development Locale With Subtype of Disease in Glioblastoma
- Atezolizumab Approved for Locally Advanced or Metastatic Urothelial Carcinoma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Initiating Palliative Care in the Emergency Department
- Implementing a Distress Screening Process for Cancer Patients
- New Research Questions Recommendations Regarding PSA Tests for Prostate Cancer Screening
- Genetic Biomarker Predictive of Peripheral Neuropathy in Patients Receiving Docetaxel for Prostate Cancer
- Specific Lifestyle Factors Can Significantly Affect Cancer Mortality
- Biomarker Indicates Which Patients With Colorectal Cancer Will Respond to Cetuximab
- Herbal Remedies May Be an Overlooked Global Health Hazard
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|